These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23255391)

  • 1. Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.
    Bollard CM; Lim MS; Gross TG;
    Pediatr Blood Cancer; 2013 Jun; 60(6):979-84. PubMed ID: 23255391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
    El-Mallawany NK; Alexander S; Fluchel M; Hayashi RJ; Lowe EJ; Giulino-Roth L; Wistinghausen B; Hermiston M; Allen CE;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30565. PubMed ID: 37449925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.
    Kelly KM; Hodgson D; Appel B; Chen L; Cole PD; Horton T; Keller FG;
    Pediatr Blood Cancer; 2013 Jun; 60(6):972-8. PubMed ID: 23255501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
    Matsuki E; Younes A
    Curr Treat Options Oncol; 2016 Jun; 17(6):31. PubMed ID: 27193488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.
    Hunger SP; Loh ML; Whitlock JA; Winick NJ; Carroll WL; Devidas M; Raetz EA;
    Pediatr Blood Cancer; 2013 Jun; 60(6):957-63. PubMed ID: 23255467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia.
    Gamis AS; Alonzo TA; Perentesis JP; Meshinchi S;
    Pediatr Blood Cancer; 2013 Jun; 60(6):964-71. PubMed ID: 23255301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma.
    Harker-Murray PD; Pommert L; Barth MJ
    J Natl Compr Canc Netw; 2020 Aug; 18(8):1125-1134. PubMed ID: 32755987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
    Castellino SM; Giulino-Roth L; Harker-Murray P; Kahn JM; Forlenza C; Cho S; Hoppe B; Parsons SK; Kelly KM;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30580. PubMed ID: 37505794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.
    Hawkins DS; Spunt SL; Skapek SX;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1001-8. PubMed ID: 23255356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment].
    Baena-Gómez MA; Mora Matilla M; Lassaletta Atienza A; Andión Catalán M; Hernández Marqués C; Madero López L
    An Pediatr (Barc); 2015 Jun; 82(6):381-7. PubMed ID: 25446790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
    Sposto R; Meadows AT; Chilcote RR; Steinherz PG; Kjeldsberg C; Kadin ME; Krailo MD; Termuhlen AM; Morse M; Siegel SE
    Med Pediatr Oncol; 2001 Nov; 37(5):432-41. PubMed ID: 11745871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting non-Hodgkin lymphoma with blinatumomab.
    Sanders S; Stewart DA
    Expert Opin Biol Ther; 2017 Aug; 17(8):1013-1017. PubMed ID: 28532177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature].
    Szegedi I; Gáspár I; Gyurina K; Zele Z; Kiss C
    Magy Onkol; 2018 Dec; 62(4):204-213. PubMed ID: 30540862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.
    Sung L; Zaoutis T; Ullrich NJ; Johnston D; Dupuis L; Ladas E;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1027-30. PubMed ID: 23255159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulation.
    Siddiqi T; Rosen ST
    Oncology (Williston Park); 2015 Apr; 29(4):299-308. PubMed ID: 25920929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children's Oncology Group's 2013 blueprint for research: radiation oncology.
    Merchant TE; Hodgson D; Laack NN; Wolden S; Indelicato DJ; Kalapurakal JA;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1037-43. PubMed ID: 23255526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vincristine liposomal--INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system--vincristine, vincacine, vincristine sulfate liposomes for injection, VSLI.
    Drugs R D; 2004; 5(2):119-23. PubMed ID: 15293876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
    Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
    J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.